Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Study evaluates the single-dose intranasal spray vaccine dNS1-RBD, finding it effective against symptomatic COVID-19, particularly in reducing severe symptoms and respiratory issues.

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly

August 24, 2023

U.S. health officials lay out plans to cope with respiratory virus season

With last fall’s chaotic early start to the respiratory virus season still fresh in the public memory, federal health authorities are trying to move quickly

August 25, 2023

Takeda says TYK2 drug it purchased for $4B has passed another mid-stage test

Takeda announced Monday morning that the TYK2 inhibitor it bought from Nimbus Therapeutics for $4 billion has succeeded in a Phase IIb trial in psoriatic

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.